Albert Friesen

Albert Friesen

Director Ejecutivo en MEDICURE INC. .

Fortuna: 2 M $ al 31/05/2026

79 años
Health Technology
Finance
Commercial Services

Perfil

Albert D.
Friesen
is the founder of Viventia Biotech, Inc. (founded 1995), Medicure, Inc. (founded 1997) where the title held is Chairman, President & Chief Executive Officer, Luminor Medical Technologies, Inc. (founded 1998) where the title held is Chairman, Winnipeg RH Institute Foundation, Inc. (founded 1971) where the title held is President, and Genesys Venture, Inc. (founded 1997) where the title held is President.
Dr. Friesen is also the founder of ABI Biotechnology, Inc.,Genesys Pharma, Inc.,KAM Scientific, Inc.,Industrial Biotechnology Association of Canada..
Dr. Friesen is Chief Executive Officer at CentreStone Ventures, Inc. since 2006.
Dr. Friesen is Chairman, President & Chief Executive Officer at Marsala Biotech Inc. Dr. Friesen is Co-Chairman at Manitoba Innovation Council.
Dr. Friesen is Chairman at Waverley Pharma, Inc. since 2016.
Dr. Friesen is Chairman & President at GVI Clinical Development Solutions, Inc. Dr. Friesen is Director at Mylan API, Inc. Dr. Friesen is Director at Magellan Biotech, Inc. Dr. Friesen is Director at Canada Foundation for Innovation since 2010.
Dr. Friesen is Director at Sensible Medical Innovations Ltd. since 2019.
Dr. Friesen was Chief Executive Officer & Director at Big Sky Petroleum Corp.
from 2006 to 2008.
Dr. Friesen was CEO, Secretary & Non-Independent Director at Buffalo Capital, Inc. Dr. Friesen was Chairman at Kane Biotech, Inc. from 2001 to 2011.
Dr. Friesen was Director at DiaMedica Therapeutics, Inc. from 2007 to 2008.
Dr. Friesen was Director at MEDA Investments, Inc. from 2000 to 2012.
Dr. Friesen was Director at Waverley Pharma, Inc. Dr. Friesen was Member-Industrial Advisory Committee at Biotechnology Research Corp.
Dr. Friesen earned a doctorate from the University of Manitoba.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
02/04/2026 2.580.827 ( 24,73 % ) 2 M $ 31/05/2026
05/05/2025 40.292.000 ( 74,61 % ) 282 044 $ 31/05/2026

Cargos activos de Albert Friesen

EmpresasCargoInicio
MEDICURE INC. Director Ejecutivo 15/09/1997
WAVERLEY PHARMA INC. Presidente 14/12/2016
Director Ejecutivo 01/01/2006
Director/Miembro de la Junta 29/01/2019
Director/Miembro de la Junta -
Director Ejecutivo -
Manitoba Innovation Council
Presidente 20/05/2011
Director/Miembro de la Junta 16/02/2010
Director/Miembro de la Junta 25/11/2009
░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░

Antiguos cargos conocidos de Albert Friesen.

EmpresasCargoFin
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Albert Friesen.

Formación de Albert Friesen.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

64

Relaciones de 1er grado

26

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas26

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Finance

Consumer Services

Finance

Commercial Services

Industrial Biotechnology Association of Canada

Finance

Miscellaneous

ABI Biotechnology, Inc.

Genesys Pharma, Inc.

Process Industries

Finance

Health Technology

Manitoba Innovation Council

Energy Minerals

Commercial Services

Finance

Health Technology

Health Technology

Health Technology

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN